DPP4 and Miyoshi myopathy: Anti-CD26mAb enhanced cytotoxicity against CD26 positive MM cells, chiefly via ADCC, direct effects and inhibition of the adhesion between MM cells and their microenvironment such as BM stromal cells [83].